Case Western Reserve University receives $1.5M grant for oral drug trial to prevent blindness in RP patients

FHS
July 8, 2024
4:25 pm

There’s only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available.

Opinion | Two Tries and We’re Done? I Don’t Think So.

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director

June 18, 2024

Biogen’s messy board, Laronde’s data problem, & the downside of a boom

Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen? We cover all that and more this

June 15, 2023

Tamoxifen lowers breast cancer recurrence in good-risk DCIS patients

For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of

December 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.